Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force. Hiromu Tanaka , Shotaro Chubachi , Ho Namkoong , Yasunori Sato , Takanori Asakura , Ho Lee , Shuhei Azekawa , Shiro Otake , Kensuke Nakagawara , Takahiro Fukushima , Mayuko Watase , Kaori Sakurai , Tatsuya Kusumoto , Yasushi Kondo , Katsunori Masaki , Hirofumi Kamata , Makoto Ishii , Yuko Kaneko , Naoki Hasegawa , Soichiro Ueda , Mamoru Sasaki , Takehiro Izumo , Minoru Inomata , Naoki Miyazawa , Yasuhiro Kimura , Yusuke Suzuki , Norihiro Harada , Masako Ichikawa , Tohru Takata , Hiroyasu Ishikura , Takashi Yoshiyama , Hiroyuki Kokuto , Koji Murakami , Hirohito Sano , Tetsuya Ueda , Naota Kuwahara , Akiko Fujiwara , Takashi Ogura , Takashi Inoue , Takahiro Asami , Yoshikazu Mutoh , Ichiro Nakachi , Rie Baba , Koichi Nishi , Mayuko Tani , Junko Kagyo , Mizuha Hashiguchi , Tsuyoshi Oguma , Koichiro Asano , Masanori Nishikawa , Hiroki Watanabe , Yukinori Okada , Ryuji Koike , Yuko Kitagawa , Akinori Kimura , Seiya Imoto , Satoru Miyano , Seishi Ogawa , Takanori Kanai , Koichi Fukunaga Open forum infectious diseases（2023）
摘要
Baricitinib is effective at preventing the need for invasive mechanical ventilation in patients with COVID-19.
更多 查看译文
关键词
baricitinib, COVID-19, invasive mechanical ventilation, real-world data
AI 理解论文
溯源树
样例
